Navigation Links
Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
Date:10/27/2010

TEMPE, Ariz., Oct. 27 /PRNewswire/ -- Intrinsic Bioprobes today announced that the United States Patents and Trademark Office has issued US Patent 7,816,095 covering novel blood protein biomarkers related to cardiovascular disease. This patent is first of a series of patent applications that cover specific human protein variants as biomarkers with clinical utility.

"The biomarkers were discovered using Intrinsic Bioprobes' unique Mass Spectrometric Immunoassay technologies," says Urban Kiernan, Ph.D., the Director of Biomarker Discovery at Intrinsic Bioprobes. These newly identified biomarkers are modified forms of specific circulating blood proteins that, when used in combination, yield exceptional clinical sensitivity and specificity in the determination of myocardial infarction. "We are very excited about these biomarkers because they clearly demonstrate the significance of protein microheterogeneity in human disease, which has been largely unexplored niche in human molecular biology," adds Kiernan.

Intrinsic Bioprobes Inc. (IBI), located in Tempe, AZ, performs unbiased discovery, verification and population studies on full-length proteins, and discovers and defines microheterogeneity in disease-associated biomarker proteins within healthy and disease populations. IBI's principal focus is the development and application of clinical and diagnostic assays and platforms for rapid and sensitive protein biomarker analysis for early detection and efficient treatment of critical human diseases. IBI's advanced technologies are patented and proprietary process platforms and approaches for proteomic and other research and clinical applications that generally leverage advanced mass spectrometry technology. These approaches include IBI's MASSAY(R) technology system, its Mass Spectrometric Immunoassay (MSIA(TM)) technology and its Bioreactive Probes (BRP(TM)). The Company has developed a deep and growing base of intellectual property in its field, consisting of 19 issued patents and numerous pending patent applications.

For more information about Intrinsic Bioprobes Inc., please visit http://www.intrinsicbio.com.Contact: Dobrin NedelkovIntrinsic Bioprobes Inc.Tel. (480) 804-1778E-mail: info@intrinsicbio.comThis press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Intrinsic Bioprobes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
2. Onyx Pharmaceuticals Announces Third Quarter 2010 Financial Results Teleconference and Webcast
3. Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
4. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
5. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
6. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
7. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
8. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
9. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
10. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
11. Roper Industries Announces Record Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 15, 2017   Mostyn Law and Gulf Coast Regional ... Texas . The Mostyn Law family has had ... That is why Mostyn Law is partnering with Gulf ... show its appreciation. Blood supplies are running low. Gulf ... of hospital needs in August. That is why the blood center ...
(Date:8/15/2017)... 2017  AOTI Inc. announced today that its fully owned ... opened a New York City Office in Yonkers, New ... Topical Wound Oxygen (TWO 2 ) homecare therapy. This new East ... Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical ... Advanced Oxygen ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) ... Chief Medical Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based ... BHI’s cutting-edge analytics solutions. , “I am thrilled to welcome Dr. Spiro to ...
(Date:8/16/2017)... ... August 16, 2017 , ... Any Lab Test Now® ... company ranked #4429 on the newly released, 36th annual Inc. 5000 , the ... look at the most successful companies within the American economy’s most dynamic segment — ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & Financial ... Partnering once again with Boys & Girls Clubs of Greater Kansas City, the ... very own American Idol. With all proceeds benefitting local worthy causes, donations may ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in ... opened clubfoot clinics in all 29 Indian states—bringing the country one step closer to ... Himachal Pradesh, the nonprofit organization is on track to enroll 10,000 children in the ...
(Date:8/16/2017)... ... 16, 2017 , ... Harbor Retirement Associates (HRA), a regional ... two of their associates were recognized with individual “Best of the Best” awards ... Florida. The awards were announced at the 5th Annual 2017 Conference, held in ...
Breaking Medicine News(10 mins):